Germany's Brenntag Q2 sales rise 11%, operating EBITDA up 41% on higher chemical pricing
Germany's Brenntag Q2 sales rise 11%, operating EBITDA up 41% on higher chemical pricing
Overview
German chemicals distributor's Q2 sales rose 11% yr/yr, operating EBITDA up 41%
Net income climbed more than fourfold to €182 mln
Company raised full-year operating EBITDA guidance to €1.35-1.45 bln
Outlook
Brenntag raises 2026 operating EBITDA outlook to €1,350 mln–1,450 mln
Result Drivers
HIGHER CHEMICAL PRICING - Co said operating EBITDA benefited from higher chemical pricing while volumes remained stable
COST SAVINGS - €41 mln in cost-out savings contributed to Q2 results, per CFO Thomas Reisten
COMMERCIAL EXECUTION - Improved customer penetration, pricing discipline, and commercial execution supported Q2 performance, per CEO Jens Birgersson
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales |
| EUR 4.26 bln |
|
Q2 EPS |
| EUR 1.23 |
|
Q2 Net Income |
| EUR 182 mln |
|
Q2 Operating EBITDA |
| EUR 463 mln |
|
Q2 Operating Gross Profit |
| EUR 1.15 bln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 14 "hold" and 3 "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy."
Wall Street's median 12-month price target for Brenntag SE is €57.00, about 8.8% below its August 11 closing price of €62.50
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 17 three months ago
Reuters Recommended Reads
Aug 10 - Activated carbon producer Arq's Q2 results beat on higher pricing, volumes in core business
Aug 10 - FutureFuel's Q2 revenue surges on volume and pricing gains
Aug 10 - Ferguson Q2 sales slightly beats on acquisitions; raises 2026 outlook
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Brenntag SE
See all newsBrief: Brenntag Enters Distribution Agreement With Almatis In Latin America
Brief: Brenntag And Cassava Pharma Sign Exclusive Distribution Agreement
German chemical industry mood rises for second straight month in September, Ifo says
Deutsche Bank AG FF - Post Stabilisation Notice- Brenntag Finance EUR 7y
Brief: Brenntag Global Partnership With DSM-Firmenich For Byphar Powered By Biond™